Treatment options for leishmaniasis

S Pradhan, RA Schwartz, A Patil… - Clinical and …, 2022 - academic.oup.com
Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and
visceral. The visceral form is most dangerous and can result in death. Although …

Efficacy of azole therapy for tegumentary leishmaniasis: a systematic review and meta-analysis

EL Galvao, A Rabello, GF Cota - PloS one, 2017 - journals.plos.org
Background Several controlled and uncontrolled studies addressing azole antifungal drugs
for cutaneous and mucosal leishmaniasis have been published with inconclusive results …

Drug delivery systems for the topical treatment of cutaneous leishmaniasis

G Carneiro, MG Aguiar, AP Fernandes… - Expert opinion on drug …, 2012 - Taylor & Francis
Introduction: The parenteral administration of pentavalent antimonials for the treatment of all
forms of leishmaniasis, including cutaneous leishamniasis (CL), has several limitations …

[HTML][HTML] TLR7 sensing by neutrophils is critical for the control of cutaneous leishmaniasis

IB Regli, K Passelli, B Martínez-Salazar, J Amore… - Cell reports, 2020 - cell.com
Neutrophils are rapidly recruited to sites of infection, where they kill invading pathogens.
However, they may also act as early temporary shelters, favoring subsequent pathogen …

Efficacy of cryotherapy for the treatment of cutaneous leishmaniasis: meta-analyses of clinical trials

L López-Carvajal, JA Cardona-Arias… - BMC infectious …, 2016 - Springer
Background Cryotherapy is a local treatment for cutaneous leishmaniasis with variable
efficacy and greater safety than conventional treatment. The objective of this study is to …

Second Generation of Mannich Base-Type Derivatives with in Vivo Activity against Trypanosoma cruzi

R Martin-Escolano, E Moreno-Viguri… - Journal of medicinal …, 2018 - ACS Publications
Chagas disease is a potentially life-threatening and neglected tropical disease caused by
Trypanosoma cruzi. One of the most important challenges related to Chagas disease is the …

[PDF][PDF] Topical treatment modalities for old world cutaneous leishmaniasis: a review

R Alavi-Naini, A Fazaeli, T O'dempsey - Prague Med Rep, 2012 - pdfs.semanticscholar.org
Diagnosis and therapy of cutaneous leishmaniasis (CL) can be difficult due to the variability
of the clinical pictures and resistance to therapy. There is no vaccine currently available for …

Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice

N Craft, R Birnbaum, N Quanquin… - Clinical and Vaccine …, 2014 - Am Soc Microbiol
New prevention and treatment strategies are needed for visceral leishmaniasis, particularly
ones that can be deployed simply and inexpensively in areas where leishmaniasis is …

Sistematización de estudios clínicos sobre la eficacia de tratamientos para la leishmaniasis cutánea 1980-2015

L López Carvajal, LC Mazo Hoyos, JA Cardona Arias - 2016 - bibliotecadigital.udea.edu.co
Introducción: A pesar de la relevancia clínica y epidemiológica de la leishmaniasis cutánea,
en la literatura científica no se dispone de una investigación que identifique y caracterice las …

[HTML][HTML] Loranthus europaeus as an alternative medicine in treatment of acute cutaneous lesihmaniasis

KE Sharquie, AA Noaimi, BA Saleh - Journal of Cosmetics, Dermatological …, 2016 - scirp.org
Loranthus europaeus (LE) is a well-known medical plant that has been used as a folk
medicine for long time ago. Recently many different researches have shown that it contains …